Health product recall

Riva-Risperidone (2021-10-07)

Starting date:
October 7, 2021
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-76621

Last updated: 2021-10-12

Summary

  • Product: Riva-Risperidone

Reason

The affected lot may contain Riva-Gabapentin 100mg capsules, however it is labelled as Riva-Risperidone 0.25mg tablets.

Depth of distribution

Wholesalers, Retailers 

Affected products

Riva-Risperidone

DIN, NPN, DIN-HIM

DIN 02283565

Dosage form

Tablet

Strength

Risperidone 0.25 mg

Lot or serial number

C9323

Companies

Recalling Firm
Laboratoire Riva Inc.
660 Industrial Blvd.
Blainville
J7C 3V4
Quebec
CANADA
Marketing Authorization Holder
Laboratoire Riva Inc.
660 Industrial Blvd.
Blainville
J7C 3V4
Quebec
CANADA